Marshall Wace North America’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-160,251
Closed -$5.82M 1627
2021
Q2
$5.82M Buy
160,251
+122,492
+324% +$4.55M 0.02% 513
2021
Q1
$1.39M Buy
37,759
+10,134
+37% +$373K 0.01% 931
2020
Q4
$1M Buy
+27,625
New +$936K ﹤0.01% 946
2020
Q1
Sell
-8,132
Closed -$345K 1497
2019
Q4
$345K Sell
8,132
-302,125
-97% -$12.8M ﹤0.01% 878
2019
Q3
$13M Sell
310,257
-74,887
-19% -$2.92M 0.07% 223
2019
Q2
$14.2M Sell
385,144
-3,100
-0.8% -$113K 0.09% 196
2019
Q1
$14.8M Buy
+388,244
New +$14.4M 0.1% 167

Other funds holding OHI

Marshall Wace North America's OHI Position: Q3 2021 in Review

Marshall Wace North America sold out of Omega Healthcare (OHI) in Q3 2021, closing a stake of 160,251 shares — an estimated $5.82M sold.

Marshall Wace North America first reported a position in OHI in Q1 2019 and held it in 7 quarters. The position peaked at $14.8M in Q1 2019. 509 funds tracked by Wall St. Rank hold OHI as of Q3 2021.

  • Marshall Wace North America reported no remaining Omega Healthcare position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 160,251 Omega Healthcare shares in Q3 2021, an estimated $5.82M.
  • Marshall Wace North America first reported a position in Omega Healthcare in Q1 2019 and held it in 7 quarters.
  • Marshall Wace North America's Omega Healthcare position peaked at $14.8M in Q1 2019.
  • 509 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.